Literature DB >> 26305620

Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease.

Qian Wu1, Margaret P Rayman1, Hongjun Lv1, Lutz Schomburg1, Bo Cui1, Chuqi Gao1, Pu Chen1, Guihua Zhuang1, Zhenan Zhang1, Xiaogang Peng1, Hua Li1, Yang Zhao1, Xiaohong He1, Gaoyuan Zeng1, Fei Qin1, Peng Hou1, Bingyin Shi1.   

Abstract

CONTEXT: Epidemiological studies have supported the premise that an adequate selenium intake is essential for thyroid gland function.
OBJECTIVE: The objective was to investigate whether the prevalence of thyroid disease differed in two areas that were similar, except for very different soil/crop selenium concentrations.
DESIGN: Cross-sectional observational study.
SETTING: The setting was two counties of Shaanxi Province, China, here defined as adequate- and low-selenium. PARTICIPANTS: A total of 6152 participants were selected by stratified cluster-sampling. MAIN OUTCOME MEASURES: Participants completed demographic and dietary questionnaires and underwent physical and thyroid ultrasound examinations. Serum samples were analyzed for thyroid function parameters and selenium concentration. Serum selenium was compared between different demographic, dietary, and lifestyle categories in the two counties. The relationship between selenium status, dietary factors, and pathological thyroid conditions was explored by logistic regression.
RESULTS: Complete data sets were available from 3038 adequate-selenium participants and 3114 low-selenium participants in whom median (interquartile range) selenium concentrations differed almost 2-fold (103.6 [79.7, 135.9] vs 57.4 [39.4, 82.1] μg/L; P = .001). The prevalence of pathological thyroid conditions (hypothyroidism, subclinical hypothyroidism, autoimmune thyroiditis, and enlarged thyroid) was significantly lower in the adequate-selenium county than in the low-selenium county (18.0 vs 30.5%; P < .001). Higher serum selenium was associated with lower odds ratio (95% confidence interval) of autoimmune thyroiditis (0.47; 0.35, 0.65), subclinical hypothyroidism (0.68; 0.58, 0.93), hypothyroidism (0.75; 0.63, 0.90), and enlarged thyroid (0.75; 0.59, 0.97).
CONCLUSIONS: Low selenium status is associated with increased risk of thyroid disease. Increased selenium intake may reduce the risk in areas of low selenium intake that exist not only in China but also in many other parts of the world.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26305620     DOI: 10.1210/jc.2015-2222

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  57 in total

1.  Selenium in the Treatment of Thyroid Diseases: An Element in Search of the Relevant Indications?

Authors:  Laszlo Hegedüs; Steen J Bonnema; Kristian H Winther
Journal:  Eur Thyroid J       Date:  2016-08-06

2.  Levothyroxine but Not Selenium Increases Endothelial Progenitor Cell Counts in Patients with Hypothyroidism.

Authors:  Roberto Negro; Giacomo Greco
Journal:  Eur Thyroid J       Date:  2016-05-12

Review 3.  Selenium in thyroid disorders - essential knowledge for clinicians.

Authors:  Kristian Hillert Winther; Margaret Philomena Rayman; Steen Joop Bonnema; Laszlo Hegedüs
Journal:  Nat Rev Endocrinol       Date:  2020-01-30       Impact factor: 43.330

4.  Influence of short-term selenium supplementation on the natural course of Hashimoto's thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial.

Authors:  D Esposito; M Rotondi; G Accardo; G Vallone; G Conzo; G Docimo; F Selvaggi; C Cappelli; L Chiovato; D Giugliano; D Pasquali
Journal:  J Endocrinol Invest       Date:  2016-08-29       Impact factor: 4.256

5.  Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the "SERENA study", a randomized, double-blind, placebo-controlled trial.

Authors:  G Mantovani; A M Isidori; C Moretti; C Di Dato; E Greco; P Ciolli; M Bonomi; L Petrone; A Fumarola; G Campagna; G Vannucchi; S Di Sante; C Pozza; A Faggiano; A Lenzi; E Giannetta
Journal:  Endocrine       Date:  2019-05-25       Impact factor: 3.633

6.  Levothyroxine monotherapy versus levothyroxine and selenium combination therapy in chronic lymphocytic thyroiditis.

Authors:  L Yu; L Zhou; E Xu; Y Bi; X Hu; X Pei; G Jin
Journal:  J Endocrinol Invest       Date:  2017-05-22       Impact factor: 4.256

7.  A 2016 Italian Survey about the Clinical Use of Selenium in Thyroid Disease.

Authors:  Roberto Negro; Roberto Attanasio; Franco Grimaldi; Claudio Marcocci; Rinaldo Guglielmi; Enrico Papini
Journal:  Eur Thyroid J       Date:  2016-08-06

Review 8.  Consequences of hyperthyroidism in male and female fertility: pathophysiology and current management.

Authors:  G Mintziori; M Kita; L Duntas; D G Goulis
Journal:  J Endocrinol Invest       Date:  2016-03-08       Impact factor: 4.256

9.  Association of serum selenium with thyroxin in severely iodine-deficient young children from the Amhara region of Ethiopia.

Authors:  D Gashu; B J Stoecker; A Adish; G D Haki; K Bougma; F E Aboud; G S Marquis
Journal:  Eur J Clin Nutr       Date:  2016-03-16       Impact factor: 4.016

10.  Lack of Association between Selenium Status and Disease Severity and Activity in Patients with Graves' Ophthalmopathy.

Authors:  Nora Dehina; Peter Josef Hofmann; Thomas Behrends; Anja Eckstein; Lutz Schomburg
Journal:  Eur Thyroid J       Date:  2016-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.